1. Home
  2. QUAD vs OABI Comparison

QUAD vs OABI Comparison

Compare QUAD & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quad Graphics Inc

QUAD

Quad Graphics Inc

HOLD

Current Price

$6.32

Market Cap

305.8M

ML Signal

HOLD

Logo OmniAb Inc.

OABI

OmniAb Inc.

HOLD

Current Price

$1.70

Market Cap

277.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUAD
OABI
Founded
1971
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Publishing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
305.8M
277.8M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
QUAD
OABI
Price
$6.32
$1.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$9.10
$6.67
AVG Volume (30 Days)
123.2K
418.4K
Earning Date
02-17-2026
03-17-2026
Dividend Yield
4.85%
N/A
EPS Growth
N/A
N/A
EPS
0.42
N/A
Revenue
$2,497,700,000.00
$21,094,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$66.20
P/E Ratio
$14.71
N/A
Revenue Growth
N/A
3.36
52 Week Low
$4.50
$1.22
52 Week High
$8.04
$4.02

Technical Indicators

Market Signals
Indicator
QUAD
OABI
Relative Strength Index (RSI) 52.88 36.38
Support Level $6.08 $1.64
Resistance Level $6.38 $1.86
Average True Range (ATR) 0.19 0.11
MACD 0.01 -0.03
Stochastic Oscillator 67.27 13.98

Price Performance

Historical Comparison
QUAD
OABI

About QUAD Quad Graphics Inc

Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America and others countries. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market..

About OABI OmniAb Inc.

OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.

Share on Social Networks: